IL13RA2 and glioblastoma: In the in vivo study, the population of mice implanted with mixed GBM was divided into four groups: those receiving control T cells, anti-EGFRvIII CAR-T cells, anti-IL-13Rα2 CAR-T cells or TanCAR-T cells.